Treating Type 1 Diabetes

Type 1 Diabetes
Type 1 Diabetes Research

JDRF is continually striving to improve the lives of people with type 1 diabetes, with the ultimate goal of delivering a cure for type 1 diabetes and its complications. 

Treat

For those who are living with type 1 diabetes, JDRF is helping to fund research into new devices and therapies to optimise glucose control and better manage and prevent the complications of diabetes.

The Basic Challenges of Living With Type 1 Diabetes

Despite significant advances in the treatment of type 1 diabetes over the past 30 years, glucose control remains a tremendous challenge. People with the disease must constantly think about how they are managing the disease with finger prick blood glucose testing, and injections or a constant infusion of insulin through an insulin pump.

Research shows that people with type 1 diabetes spend a very significant portion of the day either hyperglycaemic (too high blood sugar levels) or hypoglycaemic (too low blood sugar levels), with severe episodes of this potentially being fatal. 

Previous JDRF research has proven that there is a link between glucose control and both the onset and progression of diabetic retinopathy, diabetic neuropathy, and diabetic nephropathy (eye disease, nerve disease and kidney disease). We also know that there are significant benefits of intensive glucose management in reducing cardiovascular disease.

Fortunately, the risk of developing diabetes-related health complications continues to decrease. However, normal blood glucose level control can still be very difficult to achieve and the management of diabetes remains a difficult daily task for people with type 1 diabetes as well as their loved ones. 

Our TREAT research priorities in FY18 focus on:

  • Development of next generation artificial pancreas systems
  • Discovery and development of glucose responsive insulins
  • Predictive markers of complications of T1D and research for therapies for kidney damage/eye damage

Read more about recent research on our blog.